US1252691001 - Common Stock
We assign a fundamental rating of 6 out of 10 to CF. CF was compared to 123 industry peers in the Chemicals industry. CF has a great profitability rating, but there are some minor concerns on its financial health. CF is valued quite cheap, while showing a decent growth score. This is a good combination!
ROA (11.96%) VS Industry: 85% outperformed.
ROE (41.2%) VS Industry: 86% outperformed.
Profit Margin (19.73%) VS Industry: 92% outperformed.
Price/Earnings (11.25) VS Industry: 56% outperformed.
Price/Book (4.56) VS Industry: 18% outperformed.
Enterprise Value/ EBITDA (4.07) VS Industry: 86% outperformed.
Debt/Equity (0.74) VS Industry: 37% outperformed.
Quick Ratio (1.5) VS Industry: 59% outperformed.
Current Ratio (1.72) VS Industry: 38% outperformed.
Altman-Z (2.85) VS Industry: 52% outperformed.
Dividend Yield (1.76%) VS Industry: 37% outperformed.
NYSE:CF (6/28/2022, 11:17:10 AM)+0.59 (+0.68%)
|Earnings (Last)||05-04 2022-05-04/amc||Earnings (Next)||08-01 2022-08-01|
|Ins Owners||0.5%||Inst Owners||193.21%|
|PEG (NY)||0.03||PEG (5Y)||0.2|
|EPS 1Y||302.59%||EPS 3Y||52.48%|
|EPS 5Y||55.62%||EPS growth Q2Q||476.71%|
|EPS Next Y||347.74%||EPS Next 2Y||74.54%|
|EPS Next 3Y||23.35%||EPS Next 5Y||-5.2%|
|Revenue growth 1Y||98.95%||Revenue growth 3Y||13.86%|
|Revenue growth 5Y||12.15%||Revenue growth Q2Q||173.66%|
|Revenue Next Year||82.69%||Revenue Next 2Y||19.89%|
|Revenue Next 3Y||2.76%||Revenue Next 5Y||-8.94%|
|Current Ratio||1.72||Quick Ratio||1.5|
|Dividend Yield||1.76%||Dividend Growth||0%|
|DP||15.71%||Ex-Date||05-13 2022-05-13 (0.4)|
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA